The Nikkei has reversed early morning losses, trading up 0.5% at the moment as Chugai Pharmaceutical extended gains on expectations of strong sales of the Tamifu flu drug. Daiwa Securities has also climbed on a report of stronger ties with Sumitomo Mitsui Financial Group. Overall trade activity is limited as the market tries to grasp the seriousness of the swine flu.